Zhan, Hong <br/><br/>
Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.  [electronic resource] 

 -  PloS one  2013 
 - e77106 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0077106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD34--genetics<br/>Child<br/>Child, Preschool<br/>Female<br/>Flow Cytometry<br/>Ganciclovir--administration & dosage<br/>Genes, Transgenic, Suicide--genetics<br/>Genetic Therapy--methods<br/>Genetic Vectors--genetics<br/>Graft vs Host Disease--genetics<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Leukemia Virus, Gibbon Ape--genetics<br/>Lymphocyte Activation--immunology<br/>Male<br/>Simplexvirus--enzymology<br/>T-Lymphocytes--immunology<br/>Thymidine Kinase--genetics<br/>Transplantation, Homologous<br/>Treatment Outcome